MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells

Jian Wu; Alin Ji; Xiao Wang; Yi Zhu; Yasai Yu; Yiwei Lin; Yunfu Liu; Shiqi Li; Zhen Liang; Xin Xu; Xiangyi Zheng; Liping Xie
September 2015
Journal of Translational Medicine;9/6/2015, Vol. 13 Issue 1, p1
Academic Journal
Background: An increasing number of studies have demonstrated that deregulation of microRNAs (miRNAs) was a common event in tumor tissues and miRNAs would be treated as ideal tumor biomarkers or therapeutic targets. miR-195-5p (termed as miR-195 for briefly in the following part) was suggested to function as a tumor suppressor in cancer development and progression. However, the roles of miR-195 in human prostate cancer are still elusive. Thus, this study was performed to investigate the biological functions and its molecular mechanisms of miR-195 in human prostate cancer cell lines, discussing whether it has a potential to be a therapeutic way of prostate cancer. Methods: Two human prostate cancer cell lines were analyzed for the expression of miR-195 by quantitative realtime reverse transcription--polymerase chain reaction (RT--PCR). A gain-of-function study of miR-195 was conducted by transfecting mimics into DU145 and PC3 cells and cell motility and invasion ability were evaluated by wound healing assay and transwell assay. Tissue microarray, and immunohistochemistry with antibodies against Fra-1 was performed using the peroxidase and DAB methods. The target gene of miR-195 was determined by luciferase assay, quantitative RT--PCR and western blot. The regulation of motility by miR-195 was analyzed by western blot. Results: miR-195 was frequently down-regulated in both prostate cancer cell lines, DU145 and PC3. Overexpression of miR-195 significantly repressed the capability of migration and invasion of prostate cancer cells. In addition, we identified Fra-1, a cell motility regulator, as a novel target of miR-195. Fra-1 was up-regulated in prostate cancer tissues. We also observed that inhibition of miR-195 or restoration of Fra-1 in miR-195-over-expressed prostate cancer cells partially reversed the suppressive effects of miR-195. Furthermore, we demonstrated miR-195 could inhibit prostate cancer cell motility by regulated the expression of c-Met, MMP1, MMP9. Conclusions: miR-195 can repress the migration and invasion of prostate cancer cells via regulating Fra-1. Our results indicate that miR-195 could be a tumor suppressor and may have a potential to be a diagnostics or therapeutic target in prostate cancer.


Related Articles

  • miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes. Chen, Xuanyu; Ruan, Anming; Wang, Xuegang; Han, Weiwei; Wang, Rong; Lou, Ning; Ruan, Hailong; Qiu, Bin; Yang, Hongmei; Zhang, Xiaoping // Journal of Cancer Research & Clinical Oncology;Aug2014, Vol. 140 Issue 8, p1295 

    Purpose: Downregulation of miRNA expression has been identified as a novel feature of renal cell carcinoma (RCC). Recently, miR-129-2 is well known to be frequently reduced by DNA methylation and has anti-tumor effects in various tumors but so far not in RCC. The aim of this study was to...

  • Plasma miRNAs as Biomarkers to Identify Patients with Castration-Resistant Metastatic Prostate Cancer. Watahiki, Akira; Macfarlane, Robyn J.; Gleave, Martin E.; Crea, Francesco; Yuzhuo Wang; Helgason, Cheryl D.; Chi, Kim N. // International Journal of Molecular Sciences;Apr2013, Vol. 14 Issue 4, p7757 

    MicroRNAs (miRNAs) have emerged as key regulators of numerous biological processes, and increasing evidence suggests that circulating miRNAs may be useful biomarkers of clinical disease. In this study, we sought to identify plasma miRNAs that differentiate patients with metastatic castration...

  • Effect and mechanism of miRNA to osteosarcoma cell. Ke Tian; Limin Wang; Ruiqing Di; Jianzhong Xu; Guangheng Li; Zhifu Li // Pakistan Journal of Pharmaceutical Sciences;Sep2014, Vol. 27 Issue 5, p1657 

    MicroRNA has proved to be low expression in many tumor cells. In addition, it was also proved that as a kind of cancer suppressor gene, miR-199a-3p in miRNA can affect the growth and invasion ability of tumor cells. This paper aims to discuss the effect of miRNA to osteosarcoma cell. It used...

  • Up-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7. Xue, Zhen; Zhao, Jindong; Niu, Liyuan; An, Gang; Guo, Yashan; Ni, Linying // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Increasing reports suggest that deregulated microRNAs (miRNAs) might provide novel therapeutic targets for cancers. However, the expression and function of miR-300 in osteosarcoma is still unknown. In our study, we found that the expression of miR-300 was up-regulated in osteosarcoma tissues and...

  • miR-339-5p inhibits cell migration and invasion in vitro and may be associated with the tumor-node-metastasis staging and lymph node metastasis of non-small cell lung cancer. YUN LI; WEIGUO ZHAO; PENGTAO BAO; CHUNSUN LI; XIU QING MA; YANQING LI; LIANG AN CHEN // Oncology Letters;2014, Vol. 8 Issue 2, p719 

    The aim of the present study was to investigate the potential role of microRNA (miRNA or miR) in invasion and metastasis of non-small cell lung cancer (NSCLC). miRNA-microarray analysis was used to detect the differentially expressed miRNAs between various metastatic levels of NSCLC cells. The...

  • STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer. Zhang, Z; Liu, X; Feng, B; Liu, N; Wu, Q; Han, Y; Nie, Y; Wu, K; Shi, Y; Fan, D // Oncogene;9/10/2015, Vol. 34 Issue 37, p4808 

    STIM1 (stromal interaction molecule 1), an endoplasmic reticulum Ca2+ sensor that triggers the store-operated Ca2+ entry activation, has recently been implicated in cancer progression. However, the role of STIM1 in the progression and metastasis of colorectal cancer (CRC) has not been addressed....

  • The Angiogenic Activity of Ascites in the Course of Ovarian Cancer as a Marker of Disease Progression. Gawrychowski, Krzysztof; Szewczyk, Grzegorz; Różewska, Ewa Skopińska; Malecki, Maciej; Barcz, Ewa; Kamiński, Paweł; Miedzińska-Maciejewska, Magdalena; Śmiertka, Wacław; Szukiewicz, Dariusz; Skopiński, Piotr // Disease Markers;2014, p1 

    Ovarian cancer cells are able to create invasive implants in the peritoneum and their growth is directly associated with the angiogenetic potential. This effect is probably stimulated by vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8), which are both found in ascites. The aim...

  • HCSD: the human cancer secretome database. Feizi, Amir; Banaei-Esfahani, Amir; Nielsen, Jens // Database: The Journal of Biological Databases & Curation;2015, Vol. 2015, p1 

    The human cancer secretome database (HCSD) is a comprehensive database for human cancer secretome data. The cancer secretome describes proteins secreted by cancer cells and structuring information about the cancer secretome will enable further analysis of how this is related with tumor biology....

  • Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer. Crea, Francesco; Hurt, Elaine M.; Mathews, Lesley A.; Cabarcas, Stephanie M.; Lei Sun; Marquez, Victor E.; Danesi, Romano; Farrar, William L. // Molecular Cancer;2011, Vol. 10 Issue 1, p40 

    Background: Polycomb repressive complex 2 (PRC2) mediates gene silencing through histone H3K27 methylation. PRC2 components are over-expressed in metastatic prostate cancer (PC), and are required for cancer stem cell (CSC) self-renewal. 3-Dezaneplanocin-A (DZNeP) is an inhibitor of PRC2 with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics